Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04682522 · ClinicalTrials.gov registry record · Phase 4
Flagyl Microbiome in Crohn's Disease
A Phase 4 study of Crohn Disease, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT04682522 is a Phase 4 study of Crohn Disease that has completed, run by University of Louisville. The registered enrollment target is 4 participants, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04682522, a Phase 4 study of Crohn Disease, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the types of bacteria in the colon before and after colon resection surgery. The investigator will also compare standard post-operative antibiotic treatment to flagyl (metronidazole) treatment post-operatively to see if giving the antibiotic, decreases the incidence of return of Crohn's disease.
Conditions Studied
Interventions
- DRUG Metronidazole Oral
Study Locations (1)
Kentucky
- University Surgical Associates - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-03-21 |
| Est. Completion | 2023-08-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04682522
The ClinicalTrials.gov registry entry for NCT04682522 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 71 other Crohn Disease trials with a reported enrollment target (98% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 1 intervention - of which Metronidazole Oral is the first listed.
NCT04682522 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04682522 about?
NCT04682522 is a clinical study titled "Flagyl Microbiome in Crohn's Disease". This study will compare the types of bacteria in the colon before and after colon resection surgery. The investigator will also compare standard post-operative antibiotic treatment to flagyl (metronidazole) treatment post-operatively to see if giving the antibiotic, decreases the incidence of return...
What is the current status of trial NCT04682522?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2021-03-21. Estimated completion is 2023-08-15.
What conditions does trial NCT04682522 study?
This clinical trial studies the following conditions: Crohn Disease.
What interventions are being tested in trial NCT04682522?
The interventions under investigation include: Metronidazole Oral (DRUG).
Who is sponsoring clinical trial NCT04682522?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04682522 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
RECRUITING · Phase 4
-
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
RECRUITING · Phase 4
-
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
RECRUITING · Phase 4
-
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial
ACTIVE NOT RECRUITING · Phase 4
-
Triple Combination Therapy in High Risk Crohn's Disease (CD)
COMPLETED · Phase 4
-
Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.